Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    470.00 (10.56%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £327.71m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Grant of Options

23 Jan 2025 07:00

RNS Number : 3650U
Judges Scientific PLC
23 January 2025
Β 

23 January 2025

Β 

Judges Scientific plc

Β 

("Judges Scientific" or the "Company")

Β 

Grant of Options

Β 

Judges ScientificΒ announces that it has issued options over 76,500 new ordinary shares ofΒ 5 penceΒ each in the Company ("Ordinary Shares") at an exercise price per share ofΒ Β£76.90, being the closing mid-price onΒ 22 January 2025.

Β 

76,500 options have been awarded in total by the Remuneration Committee to certain of the Directors, as shown in the table below, to retain and incentivise them. Vesting of the options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.

Β 

Director

Number of options

Option Scheme

Vesting date

Expiry date

Tim Prestidge

60,000

Unapproved

23/01/2028

22/01/2035

David Cicurel

5,500

Unapproved

23/01/2028

22/01/2035

Brad Ormsby

5,500

Unapproved

23/01/2028

22/01/2035

Mark Lavelle

5,500

Unapproved

23/01/2028

22/01/2035

Β 

The Remuneration Committee seeks through its award of share options to motivate, retain and incentivise executives of the calibre that will grow shareholder value successfully. The share option awards align the interests of executives and shareholders. Tim Prestidge, Group Business Development Director, has been issued additional options as his original share options from the time of his appointment, which were granted on 31 March 2023, were issued with a 10% compound growth rate, prior to the enactment of the increase in UK corporation tax from 19% to 25%. In this context, the Remuneration Committee consider such compound performance target to be overly ambitious for the vesting period.Β 

Β 

Further it is noted that the Company erroneously omitted disclosing the issue of share options to Ian Wilcock, Group Commercial Director, when he joined the Company. The award of options, which was made on 19 September 2024, is summarised below.

Β 

Director

Number of options

Exercise price

Option Scheme

Vesting date

Expiry date

Ian Wilcock

305

Β£98.30

Approved

19/09/2027

19/09/2034

Ian Wilcock

29,695

Β£98.30

Unapproved

19/09/2027

19/09/2034

Β 

Β 

Β 

For further information please contact:

Β 

Β 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0)Β 20 3829 6970

Β 

Β 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

Β 

Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Joshua Borlant

TelΒ : +44 (0) 20 3100 2222

Β 

Β 

Investec Bank plcΒ (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

Β 

Notes to editors:

Judges Scientific plcΒ (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

Β 

The acquired companies are primarilyΒ UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. TheΒ UKΒ is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

Β 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Β 

Judges ScientificΒ maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

Β 

For further information, please visitΒ www.judges.uk.com

Β 

Β 

Β 

Judges Scientific plc

Director/PDMR Shareholding

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

David Cicurel

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of Options

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

7690p

Β 

5,500

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

23/01/2025

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIM Market (XLON)

Β 

Judges Scientific plc

Director/PDMR Shareholding

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Bradley Ormsby

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of Options

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

7690p

Β 

5,500

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

23/01/2025

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIM Market (XLON)

Β 

Judges Scientific plc

Director/PDMR Shareholding

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Mark Lavelle

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Operating Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of Options

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

7690p

Β 

5,500

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

23/01/2025

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIM Market (XLON)

Β 

Judges Scientific plc

Director/PDMR Shareholding

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Tim Prestidge

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Group Business Development Director

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of Options

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

7690p

Β 

60,000

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

23/01/2025

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIM Market (XLON)

Β 

Judges Scientific plc

Director/PDMR Shareholding

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Ian Wilcock

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Group Commercial Director

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Judges Scientific plc

b)

Β 

LEI

Β 

Β 

2138004EXWWPTW1JOL31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares in Judges Scientific plc

Β 

Β 

GB0032398678

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of Options

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

9830p

Β 

30,000

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

19/09/2024

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, AIM Market (XLON)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDGGDBLBDDGUD
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.